logo
15:57 Feb 04

Advanced Enzyme Technologies Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
291.85
+6.15 (+2.15%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Advanced Enzyme Technologies Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
291.85
+6.15 (+2.15%)
15:57 Feb 04
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

40/100
Technically Neutral

Strength

0

Weakness

0

Opportunity

0

Threats

0

9.22 %

ROE %

8.08 %

ROA %

0.00

EPS

127.00

BVPS

20.58 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
501.84 529.38 540.64 623.87 636.91
Operating Expenses +
270.32 327.96 384.19 419.41 442.47
Raw Material
100.21 130.33 127.53 155.47 161.96
Increase Decrease in Cost
-1.16 -20.6 4.28 -10.89 -10.1
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
87.11 103.96 114.8 128.37 141.54
Miscellaneous Expenses
84.22 114.41 137.62 146.5 149.07
Operating Profit
231.52 201.42 156.45 204.46 194.44
Other Income
8.85 6.42 25.46 36.66 33.04
Depreciation
28.41 34.98 35.03 35.24 36.56
Interest
1.59 1.8 2.42 2.93 3.56
Profit before tax and exceptio..
210.37 171.06 144.45 202.95 187.36
Exceptional Items
0 0 -4.06 -15.13 0
PBT
210.37 171.06 140.39 187.82 187.36
Provision for Taxation
58.91 47.26 36.52 50.87 53.39
Net Profit
151.46 123.8 103.87 136.95 133.97
NET Profit after MI
146.2 119.58 105.64 133.3 131.12
EPS
13.07 10.68 9.45 11.92 11.72
Operating Profit Margin (%)
46.13 38.05 28.94 32.77 30.53
Net Profit Margin (%)
29.13 22.59 19.54 21.37 20.59

Advanced Enzyme Technologies Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 43.00 43.10 43.10 43.10 42.90 43.00
FII 25.80 25.40 23.40 11.90 12.60 12.60
Public 5.60 6.40 8.50 8.20 8.10 8.00
Others 25.60 25.10 25.00 36.80 36.40 36.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: